Centene is trading 9.1% down at $58.23 as investors reassess the company's margin trajectory and updated guidance following its Q2 2026 earnings report.
- The company reported a significant EPS beat and an improved Health Benefits Ratio, while raising its full-year 2026 earnings outlook.
- Despite the positive results, the stock is seeing a sharp sell-off from its prior close of $64.08 after a significant run-up leading into the announcement.
- Investors appear to be taking profits and scrutinizing future guidance as the stock adjusts to the new financial targets.